Thursday, November 19, 2026 Latest Ford Begins LFP Cell Production, Fueling Fathom Pickup Prototypes Our standards
Health

Dr. John H. Powers III Named NIAID Director

Dr. John H. Powers III has been named the new director of the National Institute of Allergy and Infectious Diseases (NIAID), an agency managing a $6.56 billion annual budget.

Dr. John H. Powers III Named NIAID Director
Dr. John H. Powers III Named NIAID Director

Dr. John H. Powers III has been named the new director of the National Institute of Allergy and Infectious Diseases (NIAID), an agency managing a $6.56 billion annual budget.

NIH Director Jay Bhattacharya announced the selection on Monday, November 16, 2026. Dr. Powers, who currently serves as the institute’s acting director and principal deputy director, will take permanent control of the division responsible for research into infectious, immunologic, and allergic diseases.

Dr. Powers is a physician-scientist who has spent more than three decades caring for patients, teaching and mentoring the next generation of investigators, and playing an integral role in research that improves lives. He has been a trusted and valued colleague within NIAID for several decades, and will bring a focus on rigor, transparency, and research outcomes to leading the institute into the future.

Dr. Jay Bhattacharya, NIH Director

As director, Dr. Powers will oversee the implementation of a recently released research agenda and manage the institute’s massive annual budget of $6.56 billion.

A Career in Clinical Research and Regulation

Dr. Powers brings over 30 years of experience across clinical medicine, regulatory science, and infectious diseases research. Since joining NIAID in 1999 as an infectious diseases attending physician, he has also spent two decades as the Director of Collaborative Research at Leidos Biomedical Research in support of the NIAID Office of the Director.

His professional history includes a tenure at the U.S. Food and Drug Administration (FDA) from 1998 to 2006, where he served as a medical officer and later as the lead medical officer for antimicrobial drug development and resistance initiatives. During his time at the FDA, he co-chaired the U.S. Federal Interagency Task Force on Antimicrobial Resistance.

Dr. Powers has authored more than 150 peer-reviewed publications, with a specific focus on improving clinical trial design to ensure studies measure outcomes that matter to patients, such as survival, function, and quality of life. He has previously received NIH Director’s Awards for his work during both the H1N1 influenza response and the COVID-19 pandemic.

John H. Powers III to Lead NIAID Amid Turmoil
Photo: ncijnetwork.com

Leadership Transition Amid Institutional Turmoil

The permanent appointment follows a period of leadership instability within the institute. Dr. Jeffery Taubenberger, who served as acting director last year, was pushed aside, resulting in weeks of uncertainty regarding the institute’s leadership earlier this year.

The transition also occurs as the agency faces significant external pressures. Federal investigators have requested records—including phone, email, grant, and payment data—related to several infectious disease scientists, including Dr. Fauci, as part of inquiries into the origins of the COVID pandemic. Several research networks focused on H.I.V. and tuberculosis have faced delays in funding renewals due to the Trump administration.

The New York Times reported that Dr. Powers gained influence within senior health circles during the second Trump administration after being tapped to study vaccine injuries, a priority for Health Secretary Robert F. Kennedy Jr.

Emails reviewed by The New York Times indicated that early last year, Dr. Powers worked with Dr. Matthew Memoli, a No. 2 official at the NIH, to obtain CDC data regarding vaccines and autism. The correspondence suggested that while Dr. Powers and potentially other NIH contractors were set to analyze the data, autism scientists at the NIH were unaware of the requests made by NIH leadership.

Global Research and Academic Roles

The NIAID supports a vast network of research, including the Vaccine Research Center in Bethesda, Maryland, and the Rocky Mountain Laboratories in Hamilton, Montana. Dr. Powers will lead the agency’s efforts to support research at universities and small businesses both in the United States and globally.

Beyond his administrative and clinical roles, Dr. Powers holds several academic positions. He is a professor of clinical medicine at the George Washington University School of Medicine, an affiliate professor at the University of Maryland School of Pharmacy, and a research editor at The BMJ.

I am thankful for his commitment to serve and glad to permanently welcome him to the NIH leadership team.

Dr. Jay Bhattacharya, NIH Director

The agency’s leadership team looks forward to his contributions as he begins his new role overseeing vital research initiatives and supporting diverse scientific communities worldwide.

Accuracy matters. See something that needs attention? Read our corrections policy or contact the newsroom.

Health Editor

Nora Chen

Nora Chen leads TellingPointy's Health desk, covering medicine, public health, biotechnology, wellbeing, and health policy. Her desk distinguishes association from causation and early research findings from established clinical guidance.